Scalable Vial Sizing (5mg, 15mg+) What it is: Availability of the peptide in various total masses, rather than a one-size-fits-all approach
M.LacerdaA
The method of any one of embodiments 118-137, wherein the composition comprises between about 0.0001% to about 20% by weight of the therapeutic agent, about 0.0001% to about 15% by weight of the therapeutic agent, about 0.0001% to about 10% by weight of the therapeutic agent, about 0.0001% to about 5% by weight of the therapeutic agent therapeutic agent, or about 0.0001% to about 1% by weight of the therapeutic agent
1 2 3 4 Medical Hypotheses
A 6-week randomized, double-blind, placebo-controlled trial involving 31 IBS patients, who were divided into three groupsyoga plus probiotics (YPP), yoga plus placebo (YPPB), and probiotics only (P) revealed that cardiovascular endurance improved and levels of Klebsiella decreased in the YPP group